Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The Pennsylvania Department of Labor and Industry, Bureau of Workers' Compensation, has amended its rules related to Impairment Rating Evaluations (IREs). These changes aim to align the ...

Daredevil: Born Again is just over a month away from its premiere on Disney Plus on March 4, and now ratings are coming in. Not review scores, but a raqting from the BBFC, the British Board of ...

President Trump, early in his second term, is earning an approval rating among the lowest in decades, a survey found. A poll, released Thursday by Gallup, found that 47 percent of respondents ...

President Trump’s approval rate slipped after his first week back in the Oval Office, during which he issued a slew of executive orders, according to a poll published Tuesday. Trump’s ...

Stryker beats Q4 estimates with $6.44B revenue and $4.01 EPS, announces CFO retirement and spine implant business sale. Analysts raise Stryker price targets, citing strong sales, margin expansion ...

According to a national study conducted by Emerson College Polling, President Trump has started his term with a 49% approval rating. He also got a 41% disapproval rate, while 10% are neutral.

A new Emerson College poll, released Thursday, found Trump has a 49 percent job approval rating and a 41 percent disapproval rating. Another 10 percent of respondents were neutral, according to ...